Study of mRNA-1018 Pandemic Influenza Vaccines in Adults

Unknown Phase 1,Phase 2 NCT05972174

Study Description

This study aims to gather safety and immunogenicity data for mRNA-1018 pandemic influenza vaccines in healthy adults. The study will be conducted in 2 parts, evaluating multiple vaccine candidates, with the goal of initiating a larger Phase 3 trial for one selected candidate.

Study Details

Registry ID:
NCT05972174
Conditions:
Influenza
Phase:
Phase 1,Phase 2
Target Enrollment:
1,504 participants
Start Date:
Age Range:
18–999 years
Healthy Volunteers:
No

Study Locations (27 sites)

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →